Abstract
Subclinical hypothyroidism (SH), defined as an increased serum thyrotropin (TSH) level and normal plasma-free thyroid hormones’ concentrations, is common in the general population, in particular, among elderly women. Its prevalence ranges from 4 to 15% and up to 20% among females aged > 60 year. Although SH has been associated with atherosclerotic cardiovascular disease (CVD), it is acknowledged that the high prevalence of dyslipidemia in elderly people is considered a common biochemical condition. Therefore, whether SH is associated with a higher risk for CVD is still controversial. At the moment, no consensus exists on the clinical significance and treatment of the mild form of thyroid failure, although available data suggest that only patients with plasma TSH levels above 10 mU/L may have an increased risk of CVD. However, treatment of SH in older individual requires special consideration with regard to thyroid hormone replacement therapy and expected clinical outcomes, since the increase of TSH observed in this population may represent a physiological process. It is likely that age affects TSH levels, and some studies suggest that modified reference limits for elderly populations should be considered in the diagnosis of mild thyroid failure.
Similar content being viewed by others
References
Becker C (1985) Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev 6:432–440
Nedrebo BG, Ericsson UB, Nygard O et al (1998) Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism 47:89–93
Medici M, Porcu E, Pistis G et al (2014) Identification of novel genetic loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS Genet 10:e1004123
Walsh JP, Bremner AP, Feddema P et al (2010) Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab 95:1095–1104
Rugge B, Balshem H, Sehgal R et al (2011) Screening and treatment of subclinical hypothyroidism or hyperthyroidism. AHRQ Comparative Effectiveness Reviews, Rockville
Hak AE, Pols HA, Visser TJ et al (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 132:270–278
Biondi B, Cooper DS (2008) The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29:76–131
Shin DJ, Osborne TF (2003) Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2). J Biol Chem 278:34114–34118
Pearce EN (2004) Hypothyroidism and dyslipidemia: modern concepts and approaches. Curr Cardiol Rep 6:451–456
Delitala AP, Fanciulli G, Maioli M et al (2017) Subclinical hypothyroidism, lipid metabolism and cardiovascular disease. Eur J Intern Med 38:17–24
Cappola AR, Ladenson PW (2003) Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 88:2438–2444
Pearce EN (2012) Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab 97:326–333
Nilsson G, Nordlander S, Levin K (1976) Studies on subclinical hypothyroidism with special reference to the serum lipid pattern. Acta Med Scand 200:63–67
Lithell H, Boberg J, Hellsing K et al (1981) Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy. Eur J Clin Investig 11:3–10
Hueston WJ, Pearson WS (2004) Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med 2:351–355
Teixeira Pde F, Reuters VS, Ferreira MM et al (2008) Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Transl Res 151:224–231
Caraccio N, Ferrannini E, Monzani F (2002) Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 87:1533–1538
Efstathiadou Z, Bitsis S, Milionis HJ et al (2001) Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? Eur J Endocrinol 145:705–710
Adrees M, Gibney J, El-Saeity N et al (2009) Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism. Clin Endocrinol 71:298–303
Tzotzas T, Krassas GE, Konstantinidis T et al (2000) Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid 10:803–808
Brenta G, Berg G, Arias P et al (2007) Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T(4) treatment. Thyroid 17:453–460
Ito M, Takamatsu J, Sasaki I et al (2004) Disturbed metabolism of remnant lipoproteins in patients with subclinical hypothyroidism. Am J Med 117:696–699
Meisinger C, Ittermann T, Tiller D et al (2014) Sex-specific associations between thyrotropin and serum lipid profiles. Thyroid 24:424–432
Delitala AP, Steri M, Pilia MG et al (2016) Menopause modulates the association between thyrotropin levels and lipid parameters: the SardiNIA study. Maturitas 92:30–34
Villar HC, Saconato H, Valente O et al (2007) Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev:CD003419
Scuteri A, Morrell CH, Orru M et al (2014) Longitudinal perspective on the conundrum of central arterial stiffness, blood pressure, and aging. Hypertension 64:1219–1227
Dillmann WH (1996) Editorial: thyroid hormone action and cardiac contractility-a complex affair. Endocrinology 137:799–801
Danzi S, Klein I (2012) Thyroid hormone and the cardiovascular system. Med Clin North Am 96:257–268
Christ-Crain M, Meier C, Guglielmetti M et al (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 166:379–386
Chadarevian R, Bruckert E, Leenhardt L et al (2001) Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 86:732–737
Kahaly GJ (2000) Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10:665–679
Kahaly GJ, Nieswandt J, Mohr-Kahaly S (1998) Cardiac risks of hyperthyroidism in the elderly. Thyroid 8:1165–1169
Ladenson PW, Sherman SI, Baughman KL et al (1992) Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci U S A 89:5251–5255
Mariotti S, Franceschi C, Cossarizza A et al (1995) The aging thyroid. Endocr Rev 16:686–715
Cappola AR, Fried LP, Arnold AM et al (2006) Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295:1033–1041
Delitala AP, Orru M, Filigheddu F et al (2015) Serum free thyroxine levels are positively associated with arterial stiffness in the SardiNIA study. Clin Endocrinol 82:592–597
Delitala AP, Filigheddu F, Orru M et al (2015) No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque. Nutr Metab Cardiovasc Dis 25:1104–1110
Volzke H, Robinson DM, Schminke U et al (2004) Thyroid function and carotid wall thickness. J Clin Endocrinol Metab 89:2145–2149
Peixoto de Miranda EJ, Bittencourt MS, Goulart AC et al (2017) Lack of association between subclinical hypothyroidism and carotid-femoral pulse wave velocity in a cross-sectional analysis of the ELSA-Brasil. Am J Hypertens 30:81–87
Wang J, Zheng X, Sun M et al (2015) Low serum free thyroxine concentrations associate with increased arterial stiffness in euthyroid subjects: a population-based cross-sectional study. Endocrine 50:465–473
Biondi B (2012) Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur J Endocrinol 167:609–618
Suh S, Kim DK (2015) Subclinical hypothyroidism and cardiovascular disease. Endocrinol Metab (Seoul) 30:246–251
Pasqualetti G, Tognini S, Polini A et al (2013) Subclinical hypothyroidism and heart failure risk in older people. Endocr Metab Immune Disord Drug Targets 13:13–21
Razvi S, Shakoor A, Vanderpump M et al (2008) The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab 93:2998–3007
Kvetny J, Heldgaard PE, Bladbjerg EM et al (2004) Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol 61:232–238
Walsh JP, Bremner AP, Bulsara MK et al (2005) Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165:2467–2472
Rodondi N, Newman AB, Vittinghoff E et al (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460–2466
Hyland KA, Arnold AM, Lee JS et al (2013) Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 98:533–540
LeGrys VA, Funk MJ, Lorenz CE et al (2013) Subclinical hypothyroidism and risk for incident myocardial infarction among postmenopausal women. J Clin Endocrinol Metab 98:2308–2317
Ochs N, Auer R, Bauer DC et al (2008) Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 148:832–845
Rodondi N, den Elzen WP, Bauer DC et al (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365–1374
Zhao M, Yang T, Chen L et al (2015) Subclinical hypothyroidism might worsen the effects of aging on serum lipid profiles: a population-based case-control study. Thyroid 25:485–493
Pasqualetti G, Tognini S, Polini A et al (2013) Is subclinical hypothyroidism a cardiovascular risk factor in the elderly? J Clin Endocrinol Metab 98:2256–2266
Pearce SH, Brabant G, Duntas LH et al (2013) 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J 2:215–228
Volzke H, Ludemann J, Robinson DM et al (2003) The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 13:803–810
Delitala AP, Pilia MG, Ferreli L et al (2014) Prevalence of unknown thyroid disorders in a Sardinian cohort. Eur J Endocrinol 171:143–149
Lucas A, Julian MT, Canton A et al (2010) Undiagnosed thyroid dysfunction, thyroid antibodies, and iodine excretion in a Mediterranean population. Endocrine 38:391–396
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that she has no conflict of interest.
Rights and permissions
About this article
Cite this article
Decandia, F. Risk factors for cardiovascular disease in subclinical hypothyroidism. Ir J Med Sci 187, 39–43 (2018). https://doi.org/10.1007/s11845-017-1617-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-017-1617-9